Belgium· BE-AMP-SAM420481-00

Ecansya 150 mg

A capecitabine product containing capecitabine, registered in Belgium by KRKA d.d. Novo mesto. The same ATC class is registered in 17 of our 19 countries.

ATC L01BC06

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedEcansya 150 mgATCL01BC06REGISTER NO.BE-AMP-SAM420481-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Capecitabine is registered in 17 of 19 countries.

Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Capecitabine · ATC L01BC06

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of capecitabine costs, country by country.

Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Capecitabine · price per daily dose (3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$15.27
  • IT Italy$12.14
  • FR France$8.39
  • US United States$2.73 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Capecitabine
Manufacturer
KRKA d.d. Novo mesto
Country
Belgium (BE)
ATC code
L01BC06
ATC class
Capecitabine
Defined daily dose
3 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    4696175
  • be_apb
    7737752

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

366 interactions on record for capecitabine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Capecitabine · interactions on record

366 records

  • 35 severe
  • 103 moderate
  • 27 minor
  • 200 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • Folic acidB03BB01severe
  • CladribineL01BB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Capecitabine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All capecitabine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Capecel, Capecitabin Sandoz
  • Bulgaria · Капецитабин Алуфарма, Капецитабин Зентива К.С
  • Cyprus · Capecitabine Koanaa 150mg, Capecitabine Koanaa 500mg
  • Czechia · Capecitabine, Capecitabine Pharmagen
  • Germany · Capecitabin Al, Capecitabin Amarox
  • Denmark · Capecitabin Stada, Capecitabin Zentiva
  • Estonia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
  • Spain · Capecitabina Glenmark, Capecitabina Kern Pharma
  • Finland · Capecitabine Orion
  • France · Capecitabine Arrow, Capecitabine Biogaran
  • United Kingdom (Northern Ireland) · Capecitabine Amarox, Capecitabine Dr. Reddy's
  • Greece · Capecitabine Mylan, Capibine
  • Croatia · Kapecitabin Jgl 500 Mg, Kapecitabin Sandoz
  • Hungary · Capecitabin Onkogen, Capecitabine Pharmacenter
  • Iceland · Capecitabine Accord, Capecitabine Medac
  • Italy · Capecitabina Mylan, Capecitabina Zentiva
  • Liechtenstein · Capecitabine Accord, Capecitabine Medac
  • Lithuania · Capecitabine Zentiva, Capecitabine Zentiva K.S.
  • Latvia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
  • Malta · Capecitabine Pharmacare, Kapetral
  • Netherlands · Capecitabine Amarox, Capecitabine Cf
  • Norway · Capecitabine Accord, Capecitabine Medac
  • Poland · Capecitabine Glenmark
  • Portugal · Capecitabina Aurovitas, Capecitabina Farmoz
  • Romania · Capecitabină Dr. Reddy's, Cerex
  • Sweden · Capecitabin Stada, Capecitabine Orion
  • Slovenia · Kapecitabin Fresenius Kabi
  • Slovakia · Capecitabine Pharmacenter, Capecitabine Pharmagen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cc6b3450-9a38-4050-bce3-1c8868cfca6a
GET /v1/drugs/cc6b3450-9a38-4050-bce3-1c8868cfca6a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Ecansya 150 mg",
  "name_fr": "Ecansya 150 mg",
  "name_nl": "Ecansya 150 mg",
  "amp_code": "SAM420481-00",
  "strengths": [
    "150.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Capecitabine",
    "Lactose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Capecitabine",
  "authorisation_numbers": [
    "EU/1/12/763/001",
    "EU/1/12/763/003",
    "EU/1/12/763/002",
    "EU/1/12/763/005",
    "EU/1/12/763/004",
    "EU/1/12/763/006"
  ]
}

See everything about capecitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.